Intelligently making a difference
Customized AI tool leverages DataDerm to help detect rare disorders early and advantageously.
U014 – Using Artificial Intelligence for Rare Dermatologic Diseases: Getting the Right Patients the Right Treatment at the Right Time
7:30-8:30 a.m. | Friday, March 7
Room W303A
As the enduring adage says, “There is no time like the present.” But when it comes to medicine, the present may not be soon enough. This is why physicians strive to diagnose and treat health conditions as early as possible.
A new artificial intelligence (AI) tool, Patient Finder, takes diagnostics to the next level and will be the focus of the Annual Meeting session, U014 – Using Artificial Intelligence for Rare Dermatologic Diseases: Getting the Right Patients the Right Treatment at the Right Time.
According to Marta J. Van Beek, MD, MPH, FAAD, who is executive medical director at the University of Iowa Ambulatory Clinics, patients with rare dermatologic diseases often experience misdiagnosis with subsequent inappropriate treatments, which ultimately leads to prolonged patient suffering. With the help of reliable data sources and AI, dermatologists can employ modern resources to help accurately and proactively identify these challenging conditions.
“I think all of medicine is trying to figure out how AI fits into our workflows,” said Dr. Van Beek. “Everyone wonders, will AI be able to diagnose patient conditions, in addition to decreasing administrative burden? Will it be able to find the disease earlier in the patient’s journey to get the right treatment at the right time?”
In this informative session, Dr. Van Beek will share how a group of experts used the Academy’s DataDerm™ — the largest dermatologic clinical registry in the world — to train this groundbreaking tool to detect undiagnosed patients with generalized pustular psoriasis (GPP). Similarly, Steven Daniel Daveluy, MD, FAAD, will demonstrate how the new technology can assist in identifying people who may have hidradenitis suppurativa (HS).
Drs. Van Beek and Daveluy will also consider the future application of Patient Finder and will examine the risks and responsibilities of using AI in medical settings. They will be joined by Joseph Zabinski, PhD, vice president of strategy and AI for OM1, and session director Robert Swerlick, MD, FAAD.
